SCHEMBL9013754

SCHEMBL9013754

Cc1ccccc1S(=O)(=O)CCO[C]=O

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.49
NFE2L2 Q16236 1/20 0.49
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 4/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 1/20 0.39
RAPGEF4 Q8WZA2 1/20 0.36
GAA P10253 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
POLB P06746 3/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28358893 0.84 KMT2A (0.51) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL11333204 0.80 PLCG1 (0.55) KMT2AMEN1L3MBTL1POLB
SCHEMBL7194392 0.80 KEAP1 (0.57) KEAP1NFE2L2KMT2AALDH1A1ALOX12
SCHEMBL10528432 0.79 KEAP1 (0.48) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL27040077 0.79 KEAP1 (0.48) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL13069611 0.78 KEAP1 (0.47) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL9040819 0.78 CA1 (0.46) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL14445709 0.77 KEAP1 (0.46) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL25360643 0.76 MEN1 (0.43) KMT2AMEN1ALDH1A1
SCHEMBL28051 0.75 PSIP1 (0.47) KEAP1NFE2L2KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5530124-A Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-06-25 US claimed